Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simrit Parmar

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
Leukemia & Lymphoma|August 13, 2009
Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinibDisha Dumka, Poonam Puri, Nathalie Carayol, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized studySimrit Parmar, Gabriela Rondon, Marcos de Lima, et al.
Experimental Hematology|April 27, 2005
Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cellsSurinder Kaur, Simrit Parmar, Jessica Smith, et al.
The Journal of Biological Chemistry|April 2, 2004
Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cellsSimrit Parmar, Efstratios Katsoulidis, Amit Verma, et al.
Frontiers in Immunology|September 22, 2023
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosusMi-Ae Lyu, Ximing Tang, Joseph D Khoury, et al.
Blood|March 26, 2005
Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cellsSimrit Parmar, Jessica Smith, Antonella Sassano, et al.
Cancer Research|October 6, 2005
Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromesEfstratios Katsoulidis, Yongzhong Li, Patrick Yoon, et al.
European Journal of Haematology|September 13, 2017
Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myelomaNina Shah, A Megan Cornelison, Rima Saliba, et al.
Cytotherapy|November 27, 2022
Allogeneic cord blood regulatory T cells can resolve lung inflammationMi-Ae Lyu, Meixian Huang, Ke Zeng, et al.
Blood|November 28, 2014
Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivoSimrit Parmar, Xiaoying Liu, Amer Najjar, et al.
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|August 13, 2009
Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinibDisha Dumka, Poonam Puri, Nathalie Carayol, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized studySimrit Parmar, Gabriela Rondon, Marcos de Lima, et al.
Experimental Hematology|April 27, 2005
Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cellsSurinder Kaur, Simrit Parmar, Jessica Smith, et al.
The Journal of Biological Chemistry|April 2, 2004
Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cellsSimrit Parmar, Efstratios Katsoulidis, Amit Verma, et al.
Frontiers in Immunology|September 22, 2023
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosusMi-Ae Lyu, Ximing Tang, Joseph D Khoury, et al.
Blood|March 26, 2005
Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cellsSimrit Parmar, Jessica Smith, Antonella Sassano, et al.
Cancer Research|October 6, 2005
Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromesEfstratios Katsoulidis, Yongzhong Li, Patrick Yoon, et al.
European Journal of Haematology|September 13, 2017
Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myelomaNina Shah, A Megan Cornelison, Rima Saliba, et al.
Cytotherapy|November 27, 2022
Allogeneic cord blood regulatory T cells can resolve lung inflammationMi-Ae Lyu, Meixian Huang, Ke Zeng, et al.
Blood|November 28, 2014
Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivoSimrit Parmar, Xiaoying Liu, Amer Najjar, et al.
Pageof 12